BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,674,238 | -19.1% | 132,900 | +1.8% | 0.01% | -16.7% |
| Q2 2023 | $8,253,920 | +42.1% | 130,600 | +1.2% | 0.01% | +50.0% |
| Q1 2023 | $5,808,209 | -8.1% | 129,100 | -10.5% | 0.00% | -20.0% |
| Q4 2022 | $6,317,402 | -32.1% | 144,200 | +2.1% | 0.01% | -28.6% |
| Q3 2022 | $9,310,000 | +32.1% | 141,300 | +1.3% | 0.01% | +40.0% |
| Q2 2022 | $7,046,000 | -16.5% | 139,500 | +5.6% | 0.01% | 0.0% |
| Q1 2022 | $8,439,000 | -35.7% | 132,100 | +7.8% | 0.01% | -37.5% |
| Q4 2021 | $13,121,000 | +4.2% | 122,500 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,594,000 | +17.9% | 122,500 | +0.9% | 0.01% | +14.3% |
| Q2 2021 | $10,678,000 | -9.2% | 121,400 | +0.3% | 0.01% | -12.5% |
| Q1 2021 | $11,765,000 | -11.6% | 121,000 | +1.9% | 0.01% | -11.1% |
| Q4 2020 | $13,312,000 | +23.1% | 118,700 | +1.7% | 0.01% | +12.5% |
| Q3 2020 | $10,818,000 | +21.0% | 116,700 | +1.8% | 0.01% | 0.0% |
| Q2 2020 | $8,939,000 | +68.5% | 114,600 | +26.4% | 0.01% | +33.3% |
| Q1 2020 | $5,304,000 | -25.9% | 90,700 | +1.6% | 0.01% | -14.3% |
| Q4 2019 | $7,154,000 | +11.4% | 89,300 | +2.2% | 0.01% | 0.0% |
| Q3 2019 | $6,421,000 | -12.7% | 87,400 | +12.1% | 0.01% | -12.5% |
| Q2 2019 | $7,358,000 | +25.7% | 78,000 | +6.7% | 0.01% | +33.3% |
| Q1 2019 | $5,852,000 | +55.5% | 73,100 | +4.7% | 0.01% | +20.0% |
| Q4 2018 | $3,763,000 | -29.6% | 69,800 | +1.9% | 0.01% | -16.7% |
| Q3 2018 | $5,347,000 | +23.0% | 68,500 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $4,348,000 | -29.4% | 68,500 | +1.9% | 0.01% | -37.5% |
| Q1 2018 | $6,162,000 | +26.3% | 67,200 | +3.9% | 0.01% | +60.0% |
| Q4 2017 | $4,879,000 | +36.8% | 64,700 | +26.4% | 0.01% | +25.0% |
| Q3 2017 | $3,567,000 | +37.5% | 51,200 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $2,594,000 | +40.1% | 51,200 | +10.6% | 0.00% | +50.0% |
| Q1 2017 | $1,852,000 | +59.9% | 46,300 | +12.1% | 0.00% | 0.0% |
| Q4 2016 | $1,158,000 | +29.1% | 41,300 | +36.8% | 0.00% | +100.0% |
| Q3 2016 | $897,000 | +46.6% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $612,000 | +16.1% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $527,000 | +40.9% | 30,200 | +112.7% | 0.00% | 0.0% |
| Q4 2015 | $374,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |